New Releases

February 2011: Release of ri:val v4.1

• Improved value development
• Saved user preferences
• Backups

November 2009: Release of ri:val v4.0

• Resource allocation
• Proposition of deal terms
• Sales data of 700 drugs 2003-2008
• Standard reports

July 2009: Release of ri:val v3.5

• Bottom-up sales calculation

May 2009: Release of ri:val v3.4

• Deal Structurer
• Split milestones within a phase

March 2009: Release of ri:val v3.3

• Investor's IRR

February 2009: Release of ri:val v3.2

• Multivariate sensitivity analysis

January 2009: Release of ri:val v3.1

• Profit share deals
• Updated database on sales data and success rates

September 2008: Release of ri:val v3.0

• Multi-indication projects
• Commercial milestones
• Co-development, co-promotion
• Cross royalties
• "Early royalty scheme"

August 2008: Release of ri:val v2.7

• Non-life science projects
• NPV valuations in addition to rNPV and real options

June 2008: Release of ri:val v2.6

• Negotiation tool

March 2008: Release of ri:val v2.5

• Portfolio module
• Sensitivity analysis
  

February 2008: Release of ri:val v2.4

• Export of calculations into Excel

December 2007: Release of ri:val v2.3

• Advanced sales curve modelling
• Absolute and relative sales input
• Optional phase 2a/2b split
• 5 royalty tiers
• Royalties after patent expiry
• Three way licensing agreements
• License contract value development
• 2006 drug development data